Table of Contents

• 1.1 List of Tables 4
• 1.2 List of Figures 4

2 Introduction 6

• 2.1 What Is This Report About? 6
• 2.2 Nephrology and Urology Devices Market Segmentation 6
• 2.3 Definitions of Markets Covered in the Report 7

3 Nephrology and Urology Devices Market, United Kingdom 9

• 3.1 Nephrology and Urology Devices Market, United Kingdom, Revenue ($m), 2015-2025 9
• 3.2 Nephrology and Urology Devices Market, United Kingdom, Revenue ($m), 2015-2025 11
• 3.3 Nephrology and Urology Devices Market, United Kingdom, Volume (Units), 2015-2025 13
• 3.4 Nephrology and Urology Devices Market, United Kingdom, Volume (Units), 2015-2025 15
• 3.5 Nephrology and Urology Devices Market, United Kingdom, Company Share by Revenue ($m), 2019 17

4 Renal Dialysis Equipment Market, United Kingdom 19

• 4.1 Renal Dialysis Equipment Market, United Kingdom, Revenue Mix ($m), 2019 19
• 4.2 Renal Dialysis Equipment Market, United Kingdom, Segment Contribution (%), 2019 20
• 4.3 Renal Dialysis Equipment Market, United Kingdom, Revenue ($m), 2015-2025 21
  • 4.3.1 Dialysis Accessories Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 23
  • 4.3.2 Dialysis Machines Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 26
  • 4.3.3 Vascular Access Devices for Hemodialysis Market, United Kingdom, Revenue ($m), by Segment, 2015-2025 28
• 4.4 Renal Dialysis Equipment Market, United Kingdom, Volume (Units), 2015-2025 31
  • 4.4.1 Dialysis Accessories Market, United Kingdom, Volume (Units) by Segment, 2015-2025 33
  • 4.4.2 Dialysis Machines Market, United Kingdom, Volume (Units) by Segment, 2015-2025 36
  • 4.4.3 Vascular Access Devices for Hemodialysis Market, United Kingdom, Volume (Units) by Segment, 2015-2025 38
• 4.5 Renal Dialysis Equipment Market, United Kingdom, Average Price ($), 2015-2025 41
• 4.6 Renal Dialysis Equipment Market, United Kingdom, Distribution Share by Revenue ($m), 2019 43
• 4.7 Renal Dialysis Equipment Market, United Kingdom, Company Share by Revenue ($m), 2019 44

5 Overview of Key Companies in United Kingdom, Nephrology and Urology Devices Market 46

• 5.1 Fresenius Medical Care AG & Co KGaA 46
  • 5.1.1 Company Overview 46
• 5.2 Nipro Corp 46
  • 5.2.1 Company Overview 46
• 5.3 Baxter International Inc 46
  • 5.3.1 Company Overview 46
• 5.4 Asahi Kasei Corp 47
  • 5.4.1 Company Overview 47
• 5.5 B. Braun Melsungen AG 47
  • 5.5.1 Company Overview 47
• 5.6 Toray Medical Co Ltd 47
  • 5.6.1 Company Overview 47
• 5.7 CR Bard Inc 48
  • 5.7.1 Company Overview 48

6 Nephrology and Urology Devices Market Pipeline Products 49

7 Financial Deals Landscape 51

• 7.1 Equity Offerings 51
  • 7.1.1 Renalytix AI to Raise USD14.98 Million in Private Placement of Shares 51
• 7.2 Partnerships 52
  • 7.2.1 Osprey Medical to Enter into Distribution Agreement with GE Healthcare 52
• 7.3 Venture Financing 53
  • 7.3.1 Invizius Raises Funds through Equity Financing 53
  • 7.3.2 Invizius Raises USD3.4 Million in Venture Financing 55
  • 7.3.3 Quanta Dialysis Technologies Raises USD47 Million in Series C Financing 56

8 Recent Developments 58

• 8.1 Corporate Communications 58
  • 8.1.1 Mar 02, 2020: Stryker announces new Investor Relations leader 58
  • 8.1.2 Feb 27, 2020: ConvaTec Group: Non-executive director appointment 58
  • 8.1.3 Feb 04, 2020: Solvay Ventures invests in Invizius 59
  • 8.1.4 Oct 14, 2019: Renalytix AI: Board appointment 59
  • 8.1.5 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 60
  • 8.1.6 Sep 30, 2019: Renalytix AI: Update on non-executive director appointment 60
  • 8.1.7 Aug 19, 2019: John McAdam appointed Chairman of ConvaTec 61
  • 8.1.8 Jul 29, 2019: RenalytixAI appoints Thomas McLain as President and Chief Commercial Officer 61
  • 8.1.9 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 62
  • 8.1.10 Jun 25, 2019: ConvaTec Group: Board Change 63
• 8.2 Financial Announcements 63
  • 8.2.1 Feb 28, 2020: ConvaTec Group: Audited annual results for the twelve months ended 31 December 2019 63
  • 8.2.2 Jan 29, 2020: Concepta - Trading Update 64
  • 8.2.3 Sep 17, 2019: Novita signs key UK partner supply agreement 66
  • 8.2.4 Sep 03, 2019: Renalytix AI: Preliminary results 68
  • 8.2.5 Aug 29, 2019: CooperCompanies announces third quarter 2019 results 69
  • 8.2.6 Aug 01, 2019: ConvaTec Group first half results 2019 70
  • 8.2.7 Jul 24, 2019: Boston Scientific announces results for second quarter 2019 77
• 8.3 Government and Public Interest 78
  • 8.3.1 Jul 12, 2019: Renalytix AI: US executive order on advancing american kidney health 78
• 8.4 Legal And Regulatory 79
  • 8.4.1 Sep 30, 2019: Mallinckrodt finalizes settlement to resolve "Track 1" opioid cases with the Ohio Counties of Cuyahoga and Summit 79
• 8.5 Other Significant Developments 80
  • 8.5.1 Mar 05, 2020: ADDvise signs a new agreement with Laborie with a total order value of at least MSEK 50 80
  • 8.5.2 Oct 09, 2019: £2.75 million spinout deal offers dialysis hope 80
  • 8.5.3 Aug 01, 2019: Kane Biotech announces new funding granted from CanExport Program 81
  • 8.5.4 Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility 81
  • 8.5.5 Jun 27, 2019: Genmab announces U.S. FDA approval of DARZALEX (daratumumab) in combination with Lenalidomide and Dexamethasone in frontline multiple myeloma 82
  • 8.5.6 Apr 09, 2019: Fist Assist Devices announces approval of FACT by University of Chicago Medical Center 84
• 8.6 Strategy And Business Planning 84
  • 8.6.1 Jan 08, 2020: Renalytix AI: New commercial testing facility opens in Utah 84
  • 8.6.2 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe 86

9 Appendix 87

• 9.1 Research Methodology 88
  • 9.1.1 Coverage 88
  • 9.1.2 Secondary Research 88
  • 9.1.3 Primary Research 89
  • 9.1.4 Market Modeling and Forecasting 89
  • 9.1.5 Company Share Analysis 91
  • 9.1.6 Distribution Share Analysis 91
  • 9.1.7 Benchmarking 92
• 9.2 GlobalData Consulting 92
• 9.3 Contact Us 93

United Kingdom Nephrology and Urology Devices Market Outlook to 2025 - Renal Dialysis Equipment

Summary

GlobalData’s “United Kingdom Nephrology and Urology Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United Kingdom Nephrology and Urology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Renal Dialysis Equipment.

The United Kingdom Nephrology and Urology Devices Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
- 2019 company share and distribution share data for Nephrology and Urology Devices Market.
- Global corporate-level profiles of key companies operating within the United Kingdom Nephrology and Urology Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United Kingdom Nephrology and Urology Devices is segmented as follows -
- Renal Dialysis Equipment

Reasons to Buy

The United Kingdom Nephrology and Urology Devices Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.